Top 10 search results for "Trastuzumab" in Treatments. To see all results and access other features, sign up for free.

Trastuzumab

Overview
Trastuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more

Herceptin (Trastuzumab) for Breast Cancer

What Members SayTop TipsSide EffectsCopay HelpFAQs

Herceptin (trastuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Ado-Trastuzumab Emtansine

Overview
Ado-trastuzumab emtansine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-trastuzumab emtansine may be… read more

Trazimera (Trastuzumab-Qyyp) for Breast Cancer

Trazimera (trastuzumab-qyyp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Ontruzant (Trastuzumab-Dttb) for Breast Cancer

Ontruzant (trastuzumab-dttb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Kanjinti (Trastuzumab-Anns) for Breast Cancer

Kanjinti (trastuzumab-anns) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Hercessi (Trastuzumab-Strf) for Breast Cancer

Hercessi (trastuzumab-strf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Ogivri (Trastuzumab-Dkst) for Breast Cancer

Ogivri (trastuzumab-dkst) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Herzuma (Trastuzumab-Pkrb) for Breast Cancer

Herzuma (trastuzumab-pkrb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Kadcyla (Ado-Trastuzumab Emtansine) for Breast Cancer

Kadcyla (ado-trastuzumab emtansine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain HER2-positive breast…